Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:alsoKnownAs |
rebound hyperglycemia
|
| gptkbp:canBeMistakenFor |
gptkb:dawn_phenomenon
|
| gptkbp:controversy |
existence debated in modern medicine
|
| gptkbp:counterregulatoryHormones |
gptkb:glucagon
cortisol recombinant human growth hormone epinephrine |
| gptkbp:diagnosedBy |
blood glucose monitoring
|
| gptkbp:firstDescribed |
1938
|
| https://www.w3.org/2000/01/rdf-schema#label |
Somogyi effect
|
| gptkbp:managedBy |
adjustment of insulin dosage
|
| gptkbp:mechanismOfAction |
counterregulatory hormone release
|
| gptkbp:namedAfter |
gptkb:Michael_Somogyi
|
| gptkbp:observedBy |
insulin-treated patients
|
| gptkbp:occursAfter |
gptkb:hypoglycemia
|
| gptkbp:relatedTo |
gptkb:diabetes_mellitus
|
| gptkbp:result |
hyperglycemia
|
| gptkbp:triggeredBy |
excess insulin
|
| gptkbp:bfsParent |
gptkb:Zygmund_de_Somogyi
|
| gptkbp:bfsLayer |
6
|